Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Study to Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X Syndrome
This study has suspended participant recruitment.
( pending further evaluation )
Study NCT01325740 Information provided by Seaside Therapeutics, Inc.
First Received on March 28, 2011. Last Updated on December 19, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fragile X Syndrome
More general conditions related to this trial
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Heredodegenerative Disorders, Nervous System
Mental Retardation, X-Linked
Nervous System Diseases
Sex Chromosome Disorders
Interventions listed in this trial
Sponsors listed in this trial
Seaside Therapeutics, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers